| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 807-813, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
CA Purdie, J O'Grady, J Piris, AH Wyllie and CC Bird
Department of Pathology, University of Edinburgh, United Kingdom.
The expression of the nuclear phosphoprotein p53 was studied immunohistochemically in a series of 150 benign and malignant colorectal tumors. Using monoclonal antibody PAb1801, tumors divided unequivocally into two groups on the basis of immunohistochemistry. Forty of the carcinomas (46.5%) showed positive staining but only 4 of the adenomas (8.7%) were positive (P less than 0.001). The few positive adenomas always showed moderate or severe dysplasia. Metaplastic polyps (n = 9) and small familial adenomatous polyposis-related adenomas (n = 9) were uniformly negative. Carcinomas with p53 expression did not differ from those without in terms of site, differentiation or the prognostic indicators of Dukes' stage, DNA ploidy, or tumor histology. The improved morphologic resolution available in periodate lysine paraformaldehyde dichromate (PLPD)-fixed, paraffin-embedded tissue permitted several conclusions to be made: p53 is confined to neoplastic nuclei; staining in positive tumors is heterogeneous and often more marked at the infiltrative margins; and staining intensity is dramatically reduced in mitotic cells. It is concluded that expression of immunohistochemically detectable p53 (probably representing mutated forms of the protein) occurs in some adenomas around the time of transition to carcinoma. Therefore there is an association with the appearance of infiltrative behavior but not with degree of tumor progression (including metastasis) at the time of resection.
This article has been cited by other articles:
 |
|
 |
|
  C. Shanmugam, V. R. Katkoori, N. C. Jhala, W. E. Grizzle, G. P. Siegal, and U. Manne p53 Nuclear Accumulation and Bcl-2 Expression in Contiguous Adenomatous Components of Colorectal Adenocarcinomas Predict Aggressive Tumor Behavior J. Histochem. Cytochem., March 1, 2008; 56(3): 305 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Einspahr, M. E. Martinez, R. Jiang, C.-H. Hsu, A. K. Bhattacharrya, D. J. Ahnen, E. T. Jacobs, P. S. Houlihan, C. R. Webb, D. S. Alberts, et al. Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1443 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsuda, T. Masaki, T. Watanabe, J. Kitayama, H. Nagawa, T. Muto, and Y. Ajioka Clinical Significance of MUC1 and MUC2 Mucin and p53 Protein Expression in Colorectal Carcinoma Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 89 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang Evaluation of Four Antibodies in Detecting p53 Protein for Predicting Clinicopathological and Prognostic Significance in Colorectal Adenocarcinoma Clin. Cancer Res., December 1, 1999; 5(12): 4126 - 4132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Naka, Y. Iwamoto, N. Shinohara, H. Chuman, and M. Tsuneyoshi p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases International Journal of Surgical Pathology, July 1, 1997; 5(1-2): 1 - 9. [Abstract] [PDF]
|
|
|
|
 |
|
 A.H. Wyllie, P.J. Carder, A.R. Clarke, K.J. Cripps, S. Gledhill, M.F. Greaves, S. Griffiths, D.J. Harrison, M.L. Hooper, R.G. Morris, et al. Apoptosis in Carcinogenesis: The Role of p53 Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 403 - 409. [Abstract] [PDF]
|
|
|
|
|
|
W.F. Dove, C. Luongo, C.S. Connelly, K.A. Gould, A.R. Shoemaker, A.R. Moser, and R.L. Gardner The Adenomatous Polyposis Coli Gene of the Mouse in Development and Neoplasia Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 501 - 508. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
